[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Sissi et al., 2007 - Google Patents

Tri-, tetra-and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition

Sissi et al., 2007

View PDF
Document ID
6082114614185536927
Author
Sissi C
Lucatello L
Krapcho A
Maloney D
Boxer M
Camarasa M
Pezzoni G
Menta E
Palumbo M
Publication year
Publication venue
Bioorganic & medicinal chemistry

External Links

Snippet

A recent approach in anticancer chemotherapy envisages telomerase as a potentially useful target. An attractive strategy deals with the development of compounds able to stabilize telomeric DNA in the G-quadruplex folded structure and, among them, a prominent position …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the means of detection
    • C12Q1/6818—Hybridisation assays characterised by the means of detection involving interaction of at least two labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for mutation or polymorphism detection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom

Similar Documents

Publication Publication Date Title
Sissi et al. Tri-, tetra-and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition
Ma et al. Topologies of G-quadruplex: Biological functions and regulation by ligands
Franceschin et al. Natural and synthetic G-quadruplex interactive berberine derivatives
Doria et al. Hybrid ligand–alkylating agents targeting telomeric G-quadruplex structures
Zhang et al. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA
White et al. Structure-specific recognition of quadruplex DNA by organic cations: influence of shape, substituents and charge
Perry et al. 1, 4-and 2, 6-disubstituted amidoanthracene-9, 10-dione derivatives as inhibitors of human telomerase
Rossetti et al. Perylene diimides with different side chains are selective in inducing different G-quadruplex DNA structures and in inhibiting telomerase
Sehlstedt et al. Interactions of the antiviral quinoxaline derivative 9-OH-B220 {2, 3-dimethyl-6-(dimethylaminoethyl)-9-hydroxy-6H-indolo-[2, 3-b] quinoxaline} with duplex and triplex forms of synthetic DNA and RNA
Rossetti et al. Selective interactions of perylene derivatives having different side chains with inter-and intramolecular G-quadruplex DNA structures. A correlation with telomerase inhibition
Hurley et al. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element
Jenkins Targeting multi-stranded DNA structures
Zhang et al. Synthesis and evaluation of cationic phthalocyanine derivatives as potential inhibitors of telomerase
Ma et al. Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands
Esaki et al. Design of tetraplex specific ligands: Cyclic naphthalene diimide
Alberti et al. Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase
CN101238213B (en) Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (TINA) and process for the preparation of tina
Smith et al. Unraveling the relationship between structure and stabilization of triarylpyridines as G-quadruplex binding ligands
Zagotto et al. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2, 6 and 2, 7 bis-substituted anthracenedione derivatives
Alberti et al. Nucleic acids as targets for antitelomerase agents
Pivetta et al. Perylene side chains modulate G-quadruplex conformation in biologically relevant DNA sequences
Singh et al. Use of neomycin as a structured amino‐containing side chain motif for phenanthroline‐based G‐quadruplex ligands and telomerase inhibitors
Wu et al. Development of pyridopyrimidines as potent Akt1/2 inhibitors
Basu et al. Photophysical and calorimetric studies on the binding of 9-O-substituted analogs of the plant alkaloid berberine to double stranded poly (A)
CA2514105A1 (en) Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent